|
Originally published In Press as doi:10.1074/jbc.M413184200 on February 10, 2005
Originally published In Press as doi:10.1074/jbc.M413184200 on December 28, 2004
J. Biol. Chem., Vol. 280, Issue 10, 8819-8830, March 11, 2005
DRIP150 Coactivation of Estrogen Receptor in ZR-75 Breast Cancer Cells Is Independent of LXXLL Motifs*
Jeongeun Eun Lee ,
Kyounghyun Kim ,
James C. Sacchettini ¶,
Clare V. Smith , and
Stephen Safe ¶||
From the
Department of Veterinary Physiology and Pharmacology, the Department of Biochemistry and Biophysics, Texas A&M University, College Station, Texas 77843-4466, and ¶Institute of Biosciences and Technology, Texas A&M University System Health Science Center, Houston, Texas 77030-3303
Vitamin D receptor-interacting protein 150 (DRIP150) has been identified as part of mediator-like complexes that enhance transcriptional activation of the estrogen receptor (ER) and other nuclear receptors (NRs). DRIP150 coactivates ligand-dependent ER -mediated transactivation in ZR-75 and MDA-MB-231 breast cancer cells transfected with a (luciferase) reporter construct (pERE3) regulated by three tandem estrogen-responsive elements. Coactivation of ER by DRIP150 in ZR-75 cells was activation function 2-dependent and required an intact helix 12 that typically interacts with LXXLL motifs (NR box) in p160 steroid receptor coactivators. DRIP150 contains C- and N-terminal NR boxes (amino acids 11821186 and 6973, respectively), and deletion analysis of DRIP150 showed that regions containing these sequences were not necessary for coactivation of ER . Analysis of multiple DRIP150 deletion mutants identified a 23-amino-acid sequence (789811) required for coactivation activity. Analysis of the protein crystal structure data base identified two regions at amino acids 789794 and 795804, which resembled -helical motifs in Lanuginosa lipase/histamine N-methyltransferase and hepatocyte nuclear factor 1, respectively. By using a squelching assay and specific amino acid point mutations within each -helix, the NIFSEVRVYN (795804) region was identified as the critical sequence required for the activity of DRIP150. These results demonstrate that coactivation of ER by DRIP150 in ZR-75 cells is NR box-independent and requires a novel sequence with putative -helical structure.
Received for publication, November 22, 2004
* This work was supported by National Institutes of Health Grants ES09106 and CA104116 and the Texas Agricultural Experiment Station. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
|| Sid Kyle Professor of Toxicology. To whom correspondence should be addressed: Dept. of Veterinary Physiology and Pharmacology, Texas A&M University, 4466 TAMU, Veterinary Research Bldg. 409, College Station, TX 77843-4466. Tel.: 979-845-5988; Fax: 979-862-4929; E-mail: ssafe{at}cvm.tamu.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Nath-Sain and P. A. Marignani
LKB1 Catalytic Activity Contributes to Estrogen Receptor {alpha} Signaling
Mol. Biol. Cell,
June 1, 2009;
20(11):
2785 - 2795.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Ding, C. Tomomori-Sato, S. Sato, R. C. Conaway, J. W. Conaway, and T. G. Boyer
MED19 and MED26 Are Synergistic Functional Targets of the RE1 Silencing Transcription Factor in Epigenetic Silencing of Neuronal Gene Expression
J. Biol. Chem.,
January 30, 2009;
284(5):
2648 - 2656.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Chen and R. G. Roeder
The Mediator subunit MED1/TRAP220 is required for optimal glucocorticoid receptor-mediated transcription activation
Nucleic Acids Res.,
September 25, 2007;
35(18):
6161 - 6169.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M Dougherty, W. Mazhawidza, A. R Bohn, K. A Robinson, K. A Mattingly, K. A Blankenship, M. O Huff, W. G McGregor, and C. M Klinge
Gender difference in the activity but not expression of estrogen receptors {alpha} and {beta} in human lung adenocarcinoma cells.
Endocr. Relat. Cancer,
March 1, 2006;
13(1):
113 - 134.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|